Single-Molecule Super-Resolution Microscopy Reveals Heteromeric Complexes of MET and EGFR upon Ligand Activation

Area of Science:

• Cell Biology
• Molecular Oncology
• Biophysics

Background:

• Receptor tyrosine kinases (RTKs) regulate crucial cellular functions like motility and differentiation.
• Dysregulated RTKs are implicated in cancer development and are targets for therapeutic inhibitors.
• Treatment resistance often involves receptor cross-talk, where inhibiting one RTK activates alternative pathways.

Purpose of the Study:

• To investigate the formation and dynamics of MET and epidermal growth factor receptor (EGFR) clusters.
• To determine if these receptor tyrosine kinase (RTK) clusters form heteromers.
• To explore the functional implications of these interactions in cancer cell lines.

Main Methods:

• Utilized single-molecule super-resolution microscopy to visualize MET and EGFR clusters.
• Examined receptor clusters in both fixed and living cancer cells (HeLa and BT-20).
• Employed single-protein tracking to analyze receptor diffusion dynamics in response to ligands.

Main Results:

• Demonstrated the presence of heteromeric clusters composed of both MET and EGFR in HeLa and BT-20 cells.
• Observed that ligand activation promotes the formation of these EGFR-MET heteromeric clusters.
• Showed that both MET and EGFR exhibit slower diffusion upon binding cognate or non-cognate ligands.

Conclusions:

• Provided the first static and dynamic evidence of MET-EGFR heteromeric clusters on the cell membrane.
• Correlated the formation of these clusters with the relative surface expression levels of MET and EGFR.
• These findings offer insights into potential mechanisms of resistance to RTK inhibitor therapies.